Healthcare >> CEO Interviews >> September 14, 2001
MARY BENNETT, Vice President, Operations and Communications, of Inspire
Pharmaceuticals, Inc., joined the company in March 2001. She manages a
variety of areas for Inspire, including Human Resources, Communications,
Investor Relations and Operations. Mrs. Bennett comes to Inspire from
Glaxo Wellcome, where she served as Worldwide Director for R&D Human
Resources Effectiveness, Planning and Communication. Prior to her role
in human resources, Mrs. Bennett held various roles during her 13 years
at Glaxo Wellcome, including Worldwide Director for R&D Communications,
Director of R&D Operations and Department Head of Comparative Medicine.
She also led communications for major company redesign initiatives, and
for the Glaxo Wellcome merger. Mrs. Bennett holds a BA in Behavioral
Science from National-Louis University and an MBA from Duke University. Profile
GREGORY J. MOSSINGHOFF is Senior Vice President, Chief Business Officer,
Secretary and Treasurer of Inspire Pharmaceuticals, Inc. He is also a
member of the company's Board of Directors. Since joining the company in
1998, he has been responsible for all business-related activities,
including corporate development, finance, strategic planning and
operations. He has over 13 years of experience in the pharmaceutical
industry. Prior to joining Inspire, Mr. Mossinghoff was worldwide
Director of Business Analysis at Glaxo Wellcome Plc from 1995-1998.
Before joining Glaxo Wellcome, Mr. Mossinghoff filled various positions
of increasing responsibility in business development, new product
planning, finance and operations at Roche Holding Ltd., Basel,
Switzerland, and Nutley, NJ, from 1988 to 1995. Prior to entering the
pharmaceutical industry, Mr. Mossinghoff was a stockbroker at Folger
Nolan Fleming Douglas Inc., Washington, DC, and served the Committee on
Science and Technology, US House of Representatives, as a Congressional
Intern. Mr. Mossinghoff received a BA degree in Economics from the
University of Virginia, Charlottesville, VA, and an MBA in Financial
Management and Analysis from George Mason University, Fairfax, VA. He is
a member of the Licensing Executives Society, National Association of
Corporate Directors and Biotechnology Industry Association. Profile
TWST: Could we begin with a brief historical sketch and an overview ofInspire Pharmaceuticals?
Mr. Mossinghoff: Inspire began operations in 1995, based on technology
that was licensed